The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

2.50
Hdl Handle:
http://hdl.handle.net/10029/621063
Title:
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
Authors:
Geebelen, Laurence; Lernout, Tinne; Kabamba-Mukadi, Benoît; Saegeman, Veroniek; Sprong, Hein; Van Gucht, Steven; Beutels, Philippe; Speybroeck, Niko; Tersago, Katrien
Abstract:
In Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking. Despite recommended antibiotic treatment, a proportion of Lyme patients report persisting aspecific symptoms for six months or more (e.g. fatigue, widespread musculoskeletal pain, cognitive difficulties), a syndrome now named "post-treatment Lyme disease syndrome" (PTLDS). Controversy exists on the cause, incidence and severity of PTLDS. This study aims to estimate the incidence of PTLDS in patients with Lyme borreliosis and to quantify the disease burden and economic costs associated with the different clinical manifestations of Lyme borreliosis in Belgium.
Citation:
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium. 2017, 75:42 Arch Public Health
Journal:
Arch Public Health 2017, 75(1):42
Issue Date:
2017
URI:
http://hdl.handle.net/10029/621063
DOI:
10.1186/s13690-017-0202-z
PubMed ID:
28794875
Type:
Article
Language:
en
ISSN:
0778-7367
Appears in Collections:
Miscellaneous

Full metadata record

DC FieldValue Language
dc.contributor.authorGeebelen, Laurenceen
dc.contributor.authorLernout, Tinneen
dc.contributor.authorKabamba-Mukadi, Benoîten
dc.contributor.authorSaegeman, Veronieken
dc.contributor.authorSprong, Heinen
dc.contributor.authorVan Gucht, Stevenen
dc.contributor.authorBeutels, Philippeen
dc.contributor.authorSpeybroeck, Nikoen
dc.contributor.authorTersago, Katrienen
dc.date.accessioned2018-01-09T12:25:23Z-
dc.date.available2018-01-09T12:25:23Z-
dc.date.issued2017-
dc.identifier.citationThe HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium. 2017, 75:42 Arch Public Healthen
dc.identifier.issn0778-7367-
dc.identifier.pmid28794875-
dc.identifier.doi10.1186/s13690-017-0202-z-
dc.identifier.urihttp://hdl.handle.net/10029/621063-
dc.description.abstractIn Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking. Despite recommended antibiotic treatment, a proportion of Lyme patients report persisting aspecific symptoms for six months or more (e.g. fatigue, widespread musculoskeletal pain, cognitive difficulties), a syndrome now named "post-treatment Lyme disease syndrome" (PTLDS). Controversy exists on the cause, incidence and severity of PTLDS. This study aims to estimate the incidence of PTLDS in patients with Lyme borreliosis and to quantify the disease burden and economic costs associated with the different clinical manifestations of Lyme borreliosis in Belgium.en
dc.language.isoenen
dc.rightsArchived with thanks to Archives of public health = Archives belges de sante publiqueen
dc.titleThe HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.en
dc.typeArticleen
dc.identifier.journalArch Public Health 2017, 75(1):42en

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.